Springer Nature
Browse
13046_2017_538_MOESM6_ESM.pdf (932.56 kB)

Additional file 6: Figure S5. of Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells

Download (932.56 kB)
journal contribution
posted on 2017-05-12, 05:00 authored by Amani Moraya, Jennifer Ali, Pranati Samadder, Lisa Liang, Ludivine Morrison, Tamra Werbowetski-Ogilvie, Makanjuola Ogunsina, Frank Schweizer, Gilbert Arthur, Mark Nachtigal
Dose–response curves for COV362 cells and three primary HGSOC patient samples (EOC146, EOC183A, EOC183I) to GLN (open circle) or MO-101 (closed diamond). Intersections with the dashed line approximates the CC50 value. Drug doses where there is a significant difference in cell viability between culture conditions or treatments are indicated by an asterisk (*), p < 0.05.

Funding

CancerCare Manitoba Foundation

History